NDC 55513-760

REPATHA

Evolocumab

REPATHA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Evolocumab.

Product ID55513-760_02a067d5-ee1b-4d79-aea5-d0e843246a64
NDC55513-760
Product TypeHuman Prescription Drug
Proprietary NameREPATHA
Generic NameEvolocumab
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2015-08-31
Marketing CategoryBLA / BLA
Application NumberBLA125522
Labeler NameAmgen Inc
Substance NameEVOLOCUMAB
Active Ingredient Strength140 mg/mL
Pharm ClassesPCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 55513-760-01

1 SYRINGE in 1 CARTON (55513-760-01) > 1 mL in 1 SYRINGE
Marketing Start Date2015-08-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55513-760-03 [55513076003]

REPATHA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125522
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-08-31

NDC 55513-760-02 [55513076002]

REPATHA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125522
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-08-31

NDC 55513-760-01 [55513076001]

REPATHA INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125522
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-08-31

Drug Details

Active Ingredients

IngredientStrength
EVOLOCUMAB140 mg/mL

OpenFDA Data

SPL SET ID:709338ae-ab8f-44a9-b7d5-abaabec3493a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1665895
  • 1801322
  • 1801319
  • 1665904
  • 1665906
  • 1665900
  • Pharmacological Class

    • PCSK9 Inhibitor [EPC]
    • PCSK9 Inhibitors [MoA]
    • Antibodies
    • Monoclonal [CS]

    Medicade Reported Pricing

    55513076002 REPATHA 140 MG/ML SURECLICK

    Pricing Unit: ML | Drug Type:

    NDC Crossover Matching brand name "REPATHA" or generic name "Evolocumab"

    NDCBrand NameGeneric Name
    55513-750REPATHAEvolocumab
    55513-760REPATHAEvolocumab
    55513-770REPATHAEvolocumab
    72511-750REPATHAEvolocumab
    72511-760REPATHAEvolocumab
    72511-770REPATHAREPATHA

    Trademark Results [REPATHA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    REPATHA
    REPATHA
    86436098 not registered Dead/Abandoned
    Amgen Inc.
    2014-10-27
    REPATHA
    REPATHA
    86066934 4837298 Live/Registered
    Amgen Inc.
    2013-09-17
    REPATHA
    REPATHA
    76463628 not registered Dead/Abandoned
    Amgen Inc.
    2002-11-01

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.